Overcoming mTOR resistance mutations with a new-generation mTOR inhibitorVanessa Rodrik-Outmezguine, Kevan M. Shokat, Masanori Okaniwa et al.|Nature|2016Cited by 483
Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK DependenceMoriah H. Nissan, David B. Solit, Helen Won et al.|Cancer Research|2014Cited by 310